AALL1331, Risk-Stratified Randomized Phase III Testing of Blinatumomab (IND#117467, NSC#765986) in First Relapse of Childhood B-Lymphoblastic Leukemia (B-ALL)
Recruiting participants (Starts Jan. 19, 2015)
Not accepting healthy volunteers
UTSW Principal Investigator: Tamra Lynn Slone
summary
See protocol/CiRB application
eligibility
See protocol
Participate
If you are interested in this clinical trial, please contact Lindsay Therrian on the Children’s Health Research Team.Call 214-645-7094Email
STU 122014-044
AALL1331, Risk-Stratified Randomized Phase III Testing of Blinatumomab (IND#117467, NSC#765986) in First Relapse of Childhood B-Lymphoblastic Leukemia (B-ALL)
